22157.jpg
Global Pharmaceutical Contract Manufacturing Market Report 2021: Market to Reach $130.2 Billion by 2026 - API/Bulk Drugs Segments is Projected to Account for $81.5 Billion
15 juil. 2021 07h23 HE | Research and Markets
Dublin, July 15, 2021 (GLOBE NEWSWIRE) -- The "Pharmaceutical Contract Manufacturing - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Global...
22157.jpg
US Healthcare Contract Development and Manufacturing Organization (CDMO) Market Report 2021Focus on Contract Development and Contract Manufacturing
10 juin 2021 05h28 HE | Research and Markets
Dublin, June 10, 2021 (GLOBE NEWSWIRE) -- The "US Healthcare CDMO Market 2020-2026" report has been added to ResearchAndMarkets.com's offering. The US healthcare CDMO market is estimated to grow...
22157.jpg
North American Healthcare Contract Development and Manufacturing Organization Market Report 2021 Featuring AbbVie, Baxter International, Catalent, Pfizer, Thermo Fisher Scientific & Jabil
09 juin 2021 04h58 HE | Research and Markets
Dublin, June 09, 2021 (GLOBE NEWSWIRE) -- The "North American Healthcare CDMO Market 2020-2026" report has been added to ResearchAndMarkets.com's offering. The North American healthcare CDMO market...
22157.jpg
$120+ Billion Pharmaceutical Contract Manufacturing Markets - Global Forecast to 2027
26 mai 2021 05h03 HE | Research and Markets
Dublin, May 26, 2021 (GLOBE NEWSWIRE) -- The "Global Pharmaceutical Contract Manufacturing Market - Forecast to 2027" report has been added to ResearchAndMarkets.com's offering. The pharmaceutical...
22157.jpg
Outlook on the Pharmaceuticals Contract Development & Manufacturing Global Market to 2026 - Impact of COVID-19 with Ansoff Analysis
19 mai 2021 04h23 HE | Research and Markets
Dublin, May 19, 2021 (GLOBE NEWSWIRE) -- The "Global Pharmaceuticals Contract Development & Manufacturing Market (2021-2026) by Service, End-user, Geography and the Impact of COVID-19 with...
LI Recro_Logo_Screen_600x350 (002) (002).jpg
Recro Reports First Quarter 2021 Financial Results
06 mai 2021 16h05 HE | Recro Pharma, Inc.
Revenues of $16.8 Million Represent an Increase of 70% Compared to Q4 2020 Revenue Multiple New Business Agreements Signed Facilities Expansion and Enhancements Continue Company to Host Conference...
LI Recro_Logo_Screen_600x350 (002) (002).jpg
Recro to Report Financial Results for Fourth Quarter And Year-End 2020 on February 26
19 févr. 2021 16h05 HE | Recro Pharma, Inc.
MALVERN, Pa., Feb. 19, 2021 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro”; NASD: REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and...
recro_logo.jpg
Recro Strengthens Leadership Team With Key Executive and Board Appointments
11 févr. 2021 07h00 HE | Recro Pharma, Inc.
Company Names CDMO Industry Thought Leader, Jim Miller, to Board of Directors and Selects Ryan D. Lake as Dedicated Chief Financial OfficerRecent Appointments, including CEO David Enloe, Provide...
NEU 2020_Logo_Leukocare_1400x360px_300_rgb.jpg
Leukocare starts operations in the US and opens development laboratories and offices in Boston Metropolitan Area
11 janv. 2021 08h00 HE | LEUKOCARE AG
MARTINSRIED, Germany and MUNICH, Germany and MILFORD, Mass., Jan. 11, 2021 (GLOBE NEWSWIRE) -- Germany-based formulation development specialist Leukocare opens US presence to support local...
Starton logo-pantone2112C.jpg
Starton Therapeutics Selects Formulation for Continuous Subcutaneous Lenalidomide Delivery System for CLL Treatment
11 janv. 2021 07h40 HE | Starton Therapeutics, Inc.
PARAMUS, N.J., Jan. 11, 2021 (GLOBE NEWSWIRE) -- Starton Therapeutics Inc. (“Starton” or the “Company”), a clinical stage biotechnology company powering continuous delivery of approved drugs in...